Latest News & Features
Americas
US-based Alexion Pharmaceuticals has announced its plan to acquire Syntimmune, a clinical-stage biotechnology company. 1 October 2018
article
The issue of inefficiencies in the life sciences IP market is a hot topic to be discussed at the Life Science IP Forum in London in November, as LSIPR finds out. 1 October 2018
article
US company KSQ Therapeutics, a specialist in using CRISPR for drug development, has raised $80 million in series C funding. 28 September 2018
Americas
A Brazilian federal judge has granted a preliminary injunction against a patent for US-based Gilead’s Sovaldi drug, used to treat hepatitis C, following a complaint by a presidential candidate. 27 September 2018
Americas
While personalised medicine is a challenging area for drug developers, there are a number of potential solutions, as LSIPR finds out. 27 September 2018
Americas
Gilead is set to produce cheaper authorised generic versions of its branded hepatitis C treatments from 2019. 26 September 2018
Americas
US-based Encoditech yesterday accused a Roche subsidiary of infringing a patent related to wireless communication. 26 September 2018
Biotechnology
Big data presents an array of opportunities for the pharmaceutical industry, but companies must be careful who they partner with, said Myra McCormack, associate patent counsel at Johnson & Johnson, yesterday. 26 September 2018
Americas
‘Evergreening’, ‘delinking’ and a UN report on access to medicines were all up for debate yesterday, during a panel session at the 2018 AIPPI World Congress in Cancún, Mexico. 26 September 2018
Americas
The inter partes review process has had a huge impact on biosimilar litigation, but it isn’t truly fulfilling its goal of being an alternative to district court litigation. 26 September 2018